Top-News
Pharmazeutika USA

Charles River Laboratories International News

Aktie
WKN:  939391 ISIN:  US1598641074 US-Symbol:  CRL
211,00 €
+2,10 €
+1,01%
11:44:02 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
51,30 Mio.
Marktkapitalisierung *
10,86 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
S&P 500
IR-Website
zur Website
*Stand: 18.01.2024
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,48: ME8SH9

Charles River Laboratories International News

02.05.24 - Businesswire
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (LVV) portfolio, ...
09.04.24 - Businesswire
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a plasmid DNA contract development and manufacturing organization (CDMO) collaboration with Axovia ...
04.04.24 - Businesswire
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-​resistant homeobox (HOX) family biologics, today ...
04.04.24 - Businesswire
Charles River to Perform Plasmid Production for Ship of Theseus
Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-​resistant homeobox (HOX) family biologics, today ...
01.04.24 - Businesswire
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that its industry-​leading team of oncology experts will attend the American Association for Cancer ...
21.03.24 - Businesswire
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine), a leading medical ...
14.03.24 - Businesswire
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
Charles River Laboratories International, Inc. (NYSE: CRL) and Navega Therapeutics , Inc., a biotechnology company developing epigenetic gene therapies, today announced an ...
29.02.24 - PR Newswire
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use
Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-​in-Human Use PR Newswire
21.02.24 - Businesswire
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing ...
20.02.24 - LYNX Analysen
Die Kunst erfolgreicher Investments
Es gibt zahllose Strategien, die darauf abzielen, den Markt zu schlagen und eine überdurchschnittliche Rendite zu erzielen. Die meisten davon taugen überhaupt nichts. Jetzt ...
13.11.23 - PR Newswire
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology PR Newswire
21.09.23 - ARIVA.DE Redaktion
S&P 500: derzeit 0,99 Prozent weniger (4.356 Pkt.)
Am Aktienmarkt ist die Stimmung für den S&P 500 zur Stunde etwas getrübt. Gegenwärtig liegt das Aktienbarometer mit 0,99 Prozent im Minus.
21.09.23 - ARIVA.DE Redaktion
Börsen USA: Leichte Verluste für den S&P 500 (4.362 Pkt.)
Die Aktie von Charles River Laboratories ist aktuell der größte Verlierer im S&P 500-Index. Der Auswahlindex verliert 0,87 Prozent auf 4.362 Punkte.
13.09.23 - ARIVA.DE Redaktion
S&P 500 heute kaum bewegt – Waters mit größtem Kursgewinn (4.474 Pkt.)
Am Aktienmarkt findet der S&P 500 gegenwärtig keine klare Richtung. Der Auswahlindex verbessert sich nur minimal um 0,24 Prozent.
21.08.23 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Charles River Laboratories International, Inc. (NYSE: CRL)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of ...
18.07.23 - ARIVA.DE Redaktion
Aktien USA: Leichte Gewinne im S&P 500 (4.558 Pkt.)
Für den S&P 500-Index verlief der bisherige Aktienhandel heute positiv. Das Kursbarometer gewinnt 54 Punkte hinzu.
18.07.23 - ARIVA.DE Redaktion
US-Aktien: S&P 500 mit leichten Zugewinnen (4.553 Pkt.)
An der Börse ist die Stimmung für den S&P 500 derzeit freundlich. Das Kursbarometer steigt deutlich um 0,70 Prozent.
18.07.23 - PR Newswire
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. Shareholders
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. ...
17.07.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRL PR Newswire
16.07.23 - PR Newswire
Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit
Kessler Topaz Meltzer & Check, LLP Notifies Charles River Laboratories International, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit PR Newswire

Newssuche

Videos

newspaper
07.05.24 -4,91%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »